The logistics services provider has set a price range for its proposed offering and will raise up to $3.4bn in proceeds, with JD.com retaining a majority stake.

The Merck and Alphabet-backed immunological disease treatment developer floated its shares below its initial price range in an IPO in the US.

Prosus will score an exit today when data analytics platform developer Similarweb floats in the US following $240m in earlier funding.

The Meituan Dianping, Tencent and Swiss Re-backed health insurance marketplace operator priced its offering at the top of its range.

The Alibaba and Telstra-backed cloud services provider has filed to float in the United States having raised a reported $445m in the past five years.

The Taiho and UPMC-backed cancer biotherapeutics developer priced its shares in the middle of their range in its initial public offering.

The cybersecurity technology provider, which counts SB Isat among its early investors, has gone public in its home country.

GV, Tencent and Gilead Sciences will exit the vaccine and infectious disease drug developer in an initial public offering sized at about $110m.

Tencent and CapitalG-backed automation technology provider UiPath has issued approximately $200m of extra shares to close its initial public offering.

3M-backed CNS disorder therapy developer Impel priced its initial public offering in the middle of its range, giving it a $290m market cap.